SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-045724
Filing Date
2024-04-19
Accepted
2024-04-19 09:00:22
Documents
16
Period of Report
2024-05-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A idya-20240418.htm   iXBRL DEF 14A 1021956
2 GRAPHIC img42053973_0.jpg GRAPHIC 83306
3 GRAPHIC img42053973_1.jpg GRAPHIC 69289
4 GRAPHIC img42053973_2.jpg GRAPHIC 79986
5 GRAPHIC img42053973_3.jpg GRAPHIC 1336147
6 GRAPHIC img42053973_4.jpg GRAPHIC 391866
  Complete submission text file 0000950170-24-045724.txt   6204248

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT idya-20240418.xsd EX-101.SCH 41172
19 EXTRACTED XBRL INSTANCE DOCUMENT idya-20240418_htm.xml XML 215615
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

IRS No.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38915 | Film No.: 24855839
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)